Effect of Social Media Support and Financial Incentives on PrEP Adherence

Not Applicable

Completed

• Conditions: Pre-Exposure Prophylaxis

• Registration Number: NCT03078153
• Lead Sponsor: George Washington University

Brief Summary

The purpose of this study is to determine if social media support and financial incentives improve adherence to Truvada as PrEP in African American, Latino and Asian MSM aged 18 to 24 living in the Washington, DC area who are at high risk for HIV acquisition.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-03-07
• Study First Submitted QC: 2017-03-07
• Study First Posted: 2017-03-13
• Study Start: 2017-04-01
• Primary Completion: 2020-12-15
• Study Completion: 2020-12-15
• Status Verified: 2021-02
• Last Update Submitted: 2021-02-01
• Last Update Posted: 2021-02-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 57

Inclusion Criteria

• Male assigned at birth (regardless of current gender identity)
• Age 18-24
• Black/African American, Latino or Asian
• HIV negative
• History of unprotected anal sex with a man in the last 6 months
• Living within the DC metropolitan statistical area and anticipate remaining within the DC area for the next 6 months
• Not enrolled in any other HIV prevention trial
• Interested in taking PrEP
• Not a current PrEP user and have not taken PrEP in the last 30 days
• Able to provide informed consent

Exclusion Criteria

• Female sex at birth
• Age younger than 18 or older than 24
• Caucasian
• HIV positive
• Actively taking PrEP or having taken PrEP within 30 days of enrollment
• Chronic hepatitis B infection
• Known renal insufficiency
• On probation or parole
• Any other conditions that the Principal Investigator may consider a contraindication to enrolling in the study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Adherence To Truvada	6 months	Level of Truvada drug levels inside red blood cells (performed by dried blood spots)

Secondary Outcome Measures

Name	Time	Method
Incidence of STIs	6 months	Positive RPR, oropharyngeal/rectal/penile chlamydia and gonorrhea during study
New Cases of HIV	6 months	Number of reactive HIV rapid and 4th generation tests

Trial Locations

Locations (1)

The GW Medical Faculty Associates; 🇺🇸 Washington, District of Columbia, United States